MORGAN STANLEY - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 30 filers reported holding VIVOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$320
-62.4%
1,6670.0%0.00%
Q2 2023$850
+77.8%
1,667
+19.1%
0.00%
Q1 2023$478
-15.1%
1,4000.0%0.00%
Q4 2022$563
-43.7%
1,400
-0.1%
0.00%
Q3 2022$1,000
-66.7%
1,401
-41.6%
0.00%
Q2 2022$3,000
-66.7%
2,400
-33.7%
0.00%
Q1 2022$9,000
+80.0%
3,621
+50.8%
0.00%
Q4 2021$5,000
-50.0%
2,401
-5.1%
0.00%
Q3 2021$10,000
+42.9%
2,530
+71.5%
0.00%
Q2 2021$7,000
+133.3%
1,475
+195.0%
0.00%
Q1 2021$3,000
-50.0%
500
-50.0%
0.00%
Q4 2020$6,0001,0000.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$618,5050.11%
PERKINS CAPITAL MANAGEMENT INC 15,000$30.00%
Apexium Financial, LP 40,667$7,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 213$410.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$38,7920.00%
STATE STREET CORP 45,650$8,7690.00%
MORGAN STANLEY 1,667$3200.00%
BlackRock Inc. 1,037$1990.00%
LPL Financial LLC 35,484$6,8160.00%
View complete list of VIVOS THERAPEUTICS INC shareholders